Express & Expedited Shipping Service
USD $48.62
Products matching the full generic name: Imidacloprid 100g/L, Moxidectin 25g/L
AustraliaAdvocate Red Spot-On Flea & Worming Treatment is a highly effective solution designed specifically for dogs weighing between 10-25kg. This treatment provides comprehensive protection against a range of parasites, ensuring your pet stays healthy and comfortable.
The Advocate Red Spot-On Treatment works by being applied directly to your dog's skin. It rapidly absorbs and starts working immediately to eliminate existing parasites and prevent new infestations.
Ensure your dog is within the correct weight range before application. Avoid contact with eyes and wash hands thoroughly after use. If irritation occurs, consult a veterinarian immediately.
Q: Can this product be used on puppies?
A: This treatment is recommended for dogs weighing 10-25kg. Consult your veterinarian for advice on treating puppies or smaller dogs.
Q: How often should I apply this treatment?
A: For best results, apply the treatment once a month.
Q: Is this product waterproof?
A: Yes, Advocate Red Spot-On is waterproof, but avoid bathing your dog for 48 hours after application to ensure maximum effectiveness.
Health Guides
Nov 01, 2026
Baricitinib safety depends on infection screening, blood tests, and prompt evaluation of new symptoms. The main concerns are serious infections, shingles, blood clots, cancer, and cardiovascular events. Blood counts, liver and kidney function, and cholesterol help guide treatment. Historical rheumat
Oct 31, 2026
Whether to repeat a dose of an oral medication depends on the medicine, formulation, and elapsed time. Vomiting within 15 minutes or seeing an intact tablet can justify considering a replacement; after an hour, another dose is usually unnecessary. These are general timing guides, not permission to r
Oct 28, 2026
Lithium monitoring combines timed blood levels with kidney, thyroid, and calcium tests to keep bipolar treatment effective and reduce toxicity risk. Testing starts before treatment and continues throughout it. Lithium has a narrow therapeutic index, so relatively small changes in blood concentration
Oct 27, 2026
Benign prostatic hyperplasia (BPH) is a noncancerous enlarged prostate. Alpha blockers ease urinary symptoms by relaxing muscle around the outlet, often within days to weeks. 5-alpha-reductase inhibitors (5-ARIs) shrink the prostate gradually and can reduce the risks of urinary retention and surgery
Oct 24, 2026
Psoriasis medications reduce inflammation, slow excessive skin-cell growth, and control plaques. They don't cure psoriasis, but effective treatment can substantially reduce symptoms and improve daily life. Treatment in brief: Topical medicines treat affected skin. Oral medicines and injected biolog
Oct 23, 2026
Vitamin B12 deficiency can cause anemia, fatigue and nerve damage, but symptoms alone can't confirm the diagnosis. Blood tests help establish whether B12 is low and whether poor intake or impaired absorption explains the result. Early treatment matters because neurological damage can become permanen
Oct 22, 2026
Parkinson's disease medications improve movement by replacing dopamine, stimulating its receptors, or slowing its breakdown. Carbidopa-levodopa remains the most effective treatment for movement symptoms, while other medicines address milder symptoms, wearing-off, or involuntary movements. Treatment
Oct 20, 2026
Methimazole for hyperthyroidism reduces excess thyroid hormone production without destroying the thyroid gland. Treatment usually starts with a higher dose, followed by blood-test-guided reductions as hormone levels return to normal. This guide to methimazole hyperthyroidism treatment covers testing
Oct 19, 2026
Atrial fibrillation medications address three goals: rate control for a fast heart rate, rhythm control for an abnormal rhythm, and stroke prevention with anticoagulants that reduce blood clots. For atrial fibrillation, the regimen depends on stroke risk, heart and kidney function, and other prescri
Oct 17, 2026
Heart failure medications reduce strain on the heart, control fluid buildup, and lower the risk of hospitalization. Several drug classes also improve survival in people with reduced ejection fraction, although medicines don't cure heart failure. Treatment usually combines medicines because each addr
